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UNIT 10.1Analysis of Oligonucleotides by
Matrix-Assisted Laser Desorption/Ionization
Time-of-Flight Mass Spectrometry
Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS; Karas et al.,
1987; Karas and Hillenkamp, 1988) is one of the most useful techniques available for
determining biomolecule mass. MALDI-MS offers high mass accuracy, good sensitivity,
simplicity, and speed, all of which make it suitable for the analysis of oligonucleotides.
Conceptually, sample analysis using MALDI-MS is relatively straightforward: the ana-
lyte of interest is mixed with an appropriate matrix and spotted on a sample plate, and the
plate is placed in the instrument for analysis. Normally, singly charged ions of oligonu-
cleotides are observed, which makes MALDI-MS spectra very easy to interpret and
simplifies the analysis of mixtures (Fig. 10.1.1). Nowadays commercial MALDI instru-
ments, usually interfaced with time-of-flight (TOF) mass analyzers, are easy to operate
and are routinely used for many types of oligonucleotide analysis. A complementary
approach to oligonucleotide analysis is electrospray ionization mass spectrometry (ESI-
MS); this approach is presented, along with a comparison of the two techniques, in UNIT 10.2.
At present MALDI-MS is utilized routinely for the analysis of 120-mer and smaller
oligonucleotides. Polymerase chain reaction (PCR) and restriction enzyme digestion
products larger than 120-mers have not yet been routinely mass analyzed, although
500-mer and larger oligodeoxynucleotides have been ionized and observed (Tang et al.,
1994a; Liu et al., 1995a; Berkenkamp et al., 1998). Poor ionization efficiencies and
fragmentation during the desorption/ionization process have been blamed for the lack of
success with higher-molecular-weight oligonucleotides (Nordhoff et al., 1993; Schneider
and Chait, 1993; Zhu et al., 1995). However, MALDI-MS has become a useful method
to rapidly identify and characterize oligonucleotides up to 120-mers, and may soon
replace the combination of Maxam-Gilbert chemical degradation and subsequent
polyacrylamide gel electrophoresis (PAGE) for sequence characterization of these sam-
ples. Only high femtomole to low picomole per microliter amounts of oligonucleotides
are needed for an analysis. Because MALDI-MS can be used to analyze mixtures,
synthetic oligonucleotides (usually <30-mers) can be characterized by their failure
sequences (Keough et al., 1993; Limbach, 1996). Exonuclease digestion has also proven
to be a versatile alternative approach for determining the sequences of moderate-length
oligonucleotides (Pieles et al., 1993; Limbach, 1996; Smirnov et al., 1996). A still
unproven, but promising, strategy for determining oligonucleotide sequences is the
analysis of prompt and metastable fragment ions (Nordhoff et al., 1995; Juhasz, 1996).
Because of MALDI-MS’s potentially greater accuracy and speed of analysis compared
to electrophoresis-based methods, considerable effort has been expended on DNA se-
quencing reaction (Sanger reaction) product readout (Murray, 1996). One strategy to
overcome the ionization and fragmentation limitations is to replace normal nucleotides
with nucleotide analogs (7-deaza- and 2′-fluoropurines) that are more stable during
MALDI-MS analysis and are tolerated by the polymerase(s) used during chain extension
and termination reactions (Kirpekar et al., 1995; Schneider and Chait, 1995; Tang et al.,
1997b). Another potential application of MALDI-MS is the analysis of PCR products as
a means to characterize disease-specific genetic mutations (Bai et al., 1994b; Ch’ang et
al., 1995; Hurst et al., 1996; Wada and Yamamoto, 1997). Affinity probes based on
hybridization between complementary strands of oligonucleotides to capture specific
oligonucleotides fragments (e.g., DNA sequencing fragments, PCR products) for poten-
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tial automated MALDI-MS analysis are being developed (Jurinke et al., 1997; Little et
al., 1997; Ross and Belgrader, 1997; Ross et al., 1997).
In this unit the practical aspects of oligonucleotide analysis by MALDI-TOF MS are
discussed, with protocols provided for certain specific procedures. Sample preparation—
including purification of the oligonucleotide, preparation of the matrix and co-matrix, and
preparation of the sample for analysis—is discussed in detail. Protocols for oligonu-
cleotide purification using ammonium-activated cation-exchange resin beads (see Basic
Protocol 1), spin columns (see Basic Protocol 2), C18 reversed-phase cartridges (see
Alternate Protocol 1), and molecular-weight-cutoff filters (see Alternate Protocol 2) are
included. Also covered are steps for preparing matrix and co-matrix solutions (see Basic
Protocol 3) and the matrix/analyte samples for analysis (see Basic Protocol 4).
In addition, an introduction to the instrumentation and its calibration is provided, along
with discussions of the technique’s application to molecular-weight measurement, oligonu-
cleotide sequencing—including a method for exonuclease-based sequencing of oligonu-
cleotides using MALDI-TOF MS (see Basic Protocol 5)—and analysis of PCR reactions.
Figure 10.1.1 MALDI mass spectrum of oligonucleotide mixture (a) prior to desalting and (b) after
desalting with ammonium-activated cation-exchange resin beads.
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OLIGONUCLEOTIDE PURIFICATION AND DESALTING
The most important criterion for successful MALDI-MS analysis of oligonucleotides is
sample preparation. Oligonucleotide sample contaminants must be reduced or removed
prior to analysis. The primary challenge to accurate molecular-weight measurements of
oligonucleotides and nucleic acids is the presence of salt adducts, which must be reduced
or completely removed. In solution, the phosphodiester backbone is completely ionized
at pH >1, and the solvent acts as a dielectric shield to reduce the repulsive Coulombic
charging. During the ionization process, this Coulombic protection is lost, which even-
tually results in the adduction of any cations that may be present in the sample solution.
These adducts shift the ion signal to higher m/z values and interfere with accurate
determination of molecular weights (Fig. 10.1.1).
Sources of Contamination
Cations can arise from any source with which the oligonucleotide sample comes into
contact, such as solvents, buffers, the mass spectrometer sample probe, solution storage
containers, and pipet tips. To reduce cation concentration, ultrapure water—water that
has been doubly distilled and deionized (e.g., “Nanopure” water, purified using a Barn-
stead/Thermolyne Nanopure system)—should always be used. Organic solvents to be
used in preparing matrix solutions may need to be desalted by distillation or using
activated ion-exchange resin beads, such as Bio-Rad AG501-X8(d) resin beads (Simmons
and Limbach, 1998).
Often the sample holder can be a source of contaminants. The sample probe and plates
must be cleaned carefully before use so that cross-contamination with the previous sample
will not interfere with the newly deposited oligonucleotides. Sonicating and washing in
organic solvents, such as methanol and acetone, effectively removes most matrices and
analytes. Further, stainless steel sample plates can be cleaned by polishing followed by
acid oxidation in a dilute inorganic solution such as 0.1 N nitric acid. The sample plates
should be rinsed with ultrapure water to eliminate residual cations. Nonmetallic sample
substrates, such as nitrocellulose and Nafion films, can be used as alternatives; these have
been demonstrated to reduce salt adducts and enhance the ion signal of oligonucleotides,
especially for those of >100-mer size (Bai et al., 1994a,b, 1995; Liu et al., 1995a).
Many buffers simply interfere with ion formation without forming intense adduct peaks.
Investigation of the tolerance limits for several common buffers (Shaler et al., 1996)
determined that oligonucleotides could be analyzed in the presence of up to 10 mM salt
or 500 mM buffer in the sample solution, and that positive ions were less affected than
negative ions by impurities.
Purification Methods
Table 10.1.1 summarizes the numerous oligonucleotide purification schemes available.
The most common approaches are presented as protocols within this unit. In all cases, after
purification, the sample may be analyzed immediately or stored (at –20°C) for future use.
Optimal MALDI-MS results will be obtained if the sample is analyzed immediately after
purification. A popular and useful method is to treat both the sample and matrix solutions
with cation-exchange resin beads, such as Bio-Rad AG50W-X8 resin beads (see Basic
Protocol 1; Nordhoff et al., 1992). Although these beads are usually obtained from the
manufacturer in the free acid form, the ammonium-activated form is preferred for MALDI-
MS; a procedure for activating the beads is described below (see Support Protocol 1).
A simple method to remove minor cations (at concentrations <10 mM) is to add an
ammonium salt, such as ammonium citrate, tartrate, or fluoride, to the matrix solution
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(Currie and Yates, 1993; Pieles et al., 1993; Zhu et al., 1996b, Cheng, 1996). Except with
2′,4′,6′-trihydroxyacetophenone (THAP), the concentration of ammonium salt should
be ≤10 mM (see section on Matrix/Analyte Preparation); otherwise, the matrix will not
crystallize well, limiting the ability to find “hot spots” that yield abundant ion signal. A
method that has been useful for desalting oligonucleotides in ESI-MS (see UNIT 10.2) has
been adapted for MALDI-MS (Simmons and Limbach, 1997, 1998). In this approach organic
bases, such as triethylamine or piperidine, are used as co-matrices—i.e., are combined with
the matrix; these organic bases have high cation affinities and serve to reduce or eliminate
cation adduction at levels exceeding those obtainable with cation-exchange resin beads
for extremely salty samples. The organic bases should be treated with ion-exchange beads,
such as Bio-Rad AG501-X8(d) resin beads, before use to eliminate impurities.
A number of vendors (Millipore, Amersham Pharmacia Biotech, Boehringer Mannheim,
Amicon) offer prepackaged purification systems. These purification devices are typically
0.5- to 2.5-mL microcentrifuge tubes containing coated particles or filters that retain the
oligonucleotide and allow contaminants to be washed off the sample.
C18 reversed-phase cartridges (see Alternate Protocol 1) utilize the strong binding affinity
of oligonucleotides for the stationary-phase packing material in the presence of 2 M
triethylamine as the means of trapping the sample for purification. The oligonucleotides are
eluted with 20% aqueous acetonitrile. Sephadex G-25 spin-column purification (see Basic
Protocol 2) is a very useful, quick method (∼5 min) to eliminate most salts and buffers if the
oligonucleotide is larger than a 10-mer; generally one pass through the column yields
satisfactory results. Spin columns must be equilibrated in ultrapure water before desalting.
Molecular-weight-cutoff filters or membranes (see Alternate Protocol 2) retain oligonu-
cleotides above a certain molecular weight and allow contaminants to be washed through.
The membrane or filter is then inverted and the oligonucleotide is eluted and lyophilized.
For samples that contain a high concentration of inorganic impurities (such as PCR
products), reversed-phase high-performance liquid chromatography (HPLC), anion-ex-
change chromatography, microdialysis, or ethanol precipitation (see UNIT 10.2) followed
Table 10.1.1 Common Approaches for Desalting and Purifying Oligonucleotides and Matrixes
Prior to MALDI-TOF MS Analysis
Means of purification
(and selected manufacturers) Reference(s)
Oligonucleotides
Cation-exchange resin beads Nordhoff et al. (1992); Basic Protocol 1
Ammonium salt co-matrices Pieles et al. (1993); Basic Protocol 3
Organic base co-matrices Simmons and Limbach (1997); Basic
Protocol 3
C18 reversed-phase cartridges (Waters, Perkin Elmer,
Glen Research)
Alternate Protocol 1
Sephadex G-25 spin columns (Amersham Pharmacia
Biotech, Boehringer Mannheim)
Roskey et al. (1996); Basic Protocol 2
Molecular-weight cutoff filters (Amicon, Millipore,
Gelman Sciences)
Shaler et al. (1995); Alternate Protocol 2
Microdialysis
HPLC
Matrices
Recrystallization
Cation-exchange resin beads Nordhoff et al. (1992); Basic Protocol 3
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by lyophilization are reasonable purification techniques. Several appropriate HPLC
buffers for oligonucleotide purification are presented in Table 10.1.2.
Biotin-linked oligonucleotides can be purified using affinity chromatography (Jurinke et
al., 1997); this approach is often suitable (and preferred) for enzymatic digestion products.
BASIC
PROTOCOL 1Cation-Exchange Resin Purification of Oligonucleotides
Ammonium-activated resin beads are used to reduce salt contamination of oligonu-
cleotide mixtures prior to MALDI-MS analysis. This method can also be used to desalt
matrix solutions.
Materials
Oligonucleotide sample solution, 100 to 400 µM in ultrapure water
Ammonium-activated cation-exchange resin beads (see Support Protocol 1), either
dry or slurry
CAUTION: RNA samples are easily degraded by adventitious nucleases. If RNA is to be
purified or analyzed, all laboratory equipment must be sterilized prior to use. Use of gloves
is recommended during preparation of nucleic acid samples and solutions to avoid
contamination of glassware and other equipment. Autoclaved distilled water and the
highest available grade of salts must be used during solution preparation.
1. Place oligonucleotide sample in a test tube and add 10 to 20 mg of resin per 20 µL
sample solution.
2. Let mixture stand 5 to 20 min. Decant supernatant.
3. The sample is now ready for analysis (see Basic Protocol 4).
Overnight incubation of an oligonucleotide sample with resin beads should be avoided, as
this leads to degradation of oligonucleotide spectra (Fitzgerald et al., 1993a).
Best results are obtained if the sample is analyzed immediately, but it may instead be stored
at –20°C for later analysis.
Table 10.1.2 Common HPLC Buffers Suitable for Oligonucleotide Purification
Buffer Preparation
Reversed phase
A = 25 mM triethylammonium bicarbonate
(TEAB), pH 6
Add 7 mL triethylamine to container and fill
with water to 2 L; bubble CO2 gas (from
sublimation of dry ice) through solution for
~1.5 hr until pH reaches 6
B = 40% acetonitrile (AcCN) Add 80 mL AcCN to container and fill with
water to 2 L
Anion exchange
A = 25 mM TEAB/20% (v/v) AcCN, pH 6.4 Add 7 mL triethylamine and 400 mL AcCN to
container and fill with water to 2 L; bubble
CO2 gas through solution for ~2.5 hr until pH
reaches 6.4
B = 1 M TEAB/20% (v/v) AcCN, pH 7.6 Add 280 mL triethylamine and 400 mL AcCN
to container and fill with water to 2 L; bubble
CO2 gas through solution for at least 2.5 hr
until pH reaches 7.6
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SUPPORT
PROTOCOL 1 Ammonium Activation of Cation-Exchange Resin Beads
This protocol describes the procedure for converting free-acid cation-exchange resin
beads to the preferred ammonium form for use in Basic Protocol 1.
Materials
Ammonium acetate, HPLC grade
Ultrapure (e.g., Nanopure) water
Cation-exchange resin beads in free-acid (H-) state (e.g., Bio-Rad AG50W-X8 beads)
1. Add 30 g ammonium acetate to 250 mL ultrapure water. Stir for 1 hr.
2. Transfer the supernatant solution into a small container.
3. Add resin beads to solution, ensuring that the solution completely covers the beads
and that the mixture can be stirred easily. Stir on a stir plate overnight.
4. Filter excess solution from resin beads and air-dry the beads if desired. Transfer the
beads to a closed container and store at room temperature for future use.
The resin beads can be used for up to 12 months after activation.
BASIC
PROTOCOL 2 Spin-Column Purification of Oligonucleotides
Oligonucleotides >10-mers can be purified prior to MALDI-MS analysis using a spin
column. Alternative methods using C18 reversed-phase cartridges and molecular weight
cutoff filters are presented below (see Alternate Protocols 1 and 2). Sephadex G-25 spin
columns are efficient (95% salt free, 85% average recovery) and fast (<5 min).
Materials
Microspin column (e.g., Sephadex G-25)
Ultrapure (e.g., Nanopure) water
Oligonucleotide sample solution, 500 to 1000 µM in ultrapure water
CAUTION: RNA samples are easily degraded by adventitious nucleases. If RNA is to be
purified or analyzed, all laboratory equipment must be sterilized prior to use. Use of gloves
is recommended during preparation of nucleic acid samples and solutions to avoid
contamination of glassware and other equipment. Autoclaved distilled water and the
highest available grade of salts must be used during solution preparation.
1. Resuspend the resin in the microspin column by vortexing gently.
2. Loosen the cap of the column and open bottom closure.
3. Place the column in a 1.5-mL microcentrifuge tube for support.
4. Prespin the column for 1 min at recommended g force.
If the centrifuge is marked in rpm (revolutions per minute), using the following equation
to convert the force (× g) to rpm:
RCF (in g) = 
1.12 × r × rpm
1000

2
where r = radius in millimeters measured from center of spindle to bottom of rotor bucket.
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5. Discard the solution to waste in the 1.5-mL tube support. Resuspend the resin in 200
µL ultrapure water to rinse off residual impurities and spin 1 min at the same speed.
6. Place the column in a new 1.5-mL tube and slowly apply the sample to the center of
the angled surface of the compacted resin bed, being careful not to disturb the resin
bed. Do not allow any of the sample to flow around the sides of the bed.
7. Spin the column for 2 min at the recommended g force.
The purified sample will collect at the bottom of the support tube.
8. Lyophilize the purified sample. After lyophilization, the sample is ready for analysis
(see Basic Protocol 4).
Best results are obtained if the sample is analyzed immediately, but it may instead be stored
at –20°C for later analysis.
ALTERNATE
PROTOCOL 1C18 Reversed-Phase Cartridge Purification of Oligonucleotides
This protocol describes the use of oligonucleotide purification cartridges, commonly used
to purify machine-synthesized trityl-on oligonucleotides, for desalting oligonucleotides.
Materials
Oligonucleotide purification cartridge
Acetonitrile (AcCN), HPLC grade
2.0 M triethylammonium acetate (TEAA), HPLC grade
10 nmol oligonucleotide sample, dry
Ultrapure (e.g., Nanopure) water
CAUTION: RNA samples are easily degraded by adventitious nucleases. If RNA is to
be purified or analyzed, all laboratory equipment must be sterilized prior to use. Use of
gloves is recommended during preparation of nucleic acid samples and solutions to avoid
contamination of glassware and other equipment. Autoclaved distilled water and the
highest available grade of salts must be used during solution preparation.
1. Slowly pass first 5 mL acetonitrile, then 5 mL of 2 M TEAA, through the purification
cartridge to a waste container.
2. Dissolve the oligonucleotide sample in 1 to 3 mL ultrapure water, 0.1 M TEAA, or
other aqueous solution.
The loading solution should not contain any organic solvents or ammonium hydroxide.
3. Pass this solution through the oligonucleotide purification cartridge at a rate of ∼1
drop per second exiting the cartridge, and collect the eluate.
4. Pass the eluate through the cartridge a second time.
5. Pass 10 mL ultrapure water through the cartridge to waste.
6. Elute and collect the desalted oligonucleotide by slowly passing, drop by drop, 1 mL
of 50% acetonitrile in ultrapure water through the cartridge.
7. Lyophilize the desalted sample. After lyophilization, the sample is ready for analysis
(see Basic Protocol 4).
Best results are obtained if the sample is analyzed immediately, but it may instead be stored
at –20°C for later analysis.
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ALTERNATE
PROTOCOL 2 Molecular-Weight-Cutoff-Filter Purification of Oligonucleotides
This protocol describes the procedure for purifying oligonucleotides larger than 25-mers
prior to MALDI-MS analysis. It is essential to concentrate the sample to a small volume
prior to desalting.
Materials
Molecular-weight-cutoff-filter column
Oligonucleotide sample solution, 100 to 400 µM in ultrapure water
Ultrapure (e.g., Nanopure) water
CAUTION: RNA samples are easily degraded by adventitious nucleases. If RNA is to be
purified or analyzed, all laboratory equipment must be sterilized prior to use. Use of gloves
is recommended during preparation of nucleic acid samples and solutions to avoid
contamination of glassware and other equipment. Autoclaved distilled water and the
highest available grade of salts must be used during solution preparation.
1. Select a filter column with nucleotide cutoff equal to or smaller than the size of the
nucleic acid to be desalted (consult the manufacturer’s instructions).
2. Insert the sample reservoir into a microcentrifuge tube or into the tube supplied by
manufacturer.
3. To concentrate the sample, pipet up to 500 µL of sample solution into the reservoir.
Spin under the conditions (time and g force) recommended by the manufacturer,
being careful not to exceed the recommended force.
4. To exchange salt, dilute the concentrated sample to 500 µL with ultrapure water. Spin
under the conditions (time and g force) recommended by the manufacturer. To reduce
salt concentration further, repeat this step.
5. Remove reservoir from vial and invert into a new vial (save and store filtrate at –20°C
until sample has been analyzed).
6. Spin for 2 min at 500 to 1000 × g to recover oligonucleotide sample in the vial.
7. Remove reservoir.
8. Lyophilize sample in vial. After lyphilization, the sample is ready for analysis (see
Basic Protocol 4)
Best results are obtained if the sample is analyzed immediately, but it may instead be stored
at –20°C for later analysis.
MATRIX/ANALYTE PREPARATION
Matrix and Co-Matrix Selection
The essence of MALDI-MS is the matrix—typically a small acidic organic compound
that has a relatively high molar absorptivity (ελ) at the wavelength of the laser. Common
MALDI-MS matrices have molar absorptivities on the order of 103 to 105 M−1 cm−1. A
large number of potential matrices have been investigated over the years, with a relatively
small number becoming the standards for MALDI-MS of oligonucleotides (Fig. 10.1.2).
3-Hydroxypicolinic acid (3-HPA) has been the most useful oligonucleotide matrix, as it
consistently results in the least fragmentation (Wu et al., 1993). Picolinic acid (PA) and
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3-aminopicolinic (3-APA) acid have also been investigated (Tang et al., 1994b), but are
less practical choices, because PA works best at 266 nm and 3-APA is still not commer-
cially available (Juhasz et al., 1996). However, a mixture of PA and 3-HPA is often used
for larger oligonucleotides (Liu et al., 1995a). Other commonly used matrices include
2′,4′,6′-trihydroxyacetophenone (THAP; Pieles et al., 1993; Zhu et al., 1996a), a mixture
of anthranilic acid and nicotinic acid (AA/NA; Nordhoff et al., 1992), and 6-aza-2-
thiothymine (ATT; Lecchi et al., 1995). These are useful for smaller oligonucleotides, up
to 25 bases in length (Nordhoff et al., 1996). The popular peptide and protein matrices,
such 2,5-dihydroxybenzoic acid (DHBA; Strupat et al., 1991) and sinapinic acid (SA;
Beavis and Chait, 1989), should not be used as they yield intense prompt and metastable
fragmentation that limits the molecular ion abundance (Parr et al., 1992; Schneider and
Chait, 1993).
BASIC
PROTOCOL 3Matrix and Co-Matrix Preparation
Fresh matrix solutions should be used within a week of preparation, before they start to
degrade, and it is best to prepare them daily before use. Because most matrices have to
be dissolved in suitable solvents prior to mixing with the analyte solution, the solvent(s)
should be chosen based on the solubilities of the matrices. In all cases, a large molar excess
of matrix to analyte (103 to 105:1) is used when preparing oligonucleotides for analysis.
This protocol describes the procedure for preparing MALDI-MS matrix solutions.
Note: Optimal results are obtained when the highest-purity matrix and co-matrix are used.
Materials
One of the following matrices:
 3-Hydroxypicolinic acid (3-HPA; Aldrich or Fluka)
 3-Hydroxypicolinic acid and picolinic acid (Aldrich or Fluka; 3-HPA/PA)
N
OH
COOH
3-hydroxypicolinic acid picolinic acid
N COOH
OH
OH OH
CH3O
2',4',6'-trihydroxyacetophenone 6-azathiothymine
HN
N
H
NS
O
CH3
N
COOH
nicotinic acid
NH2
COOH
anthranilic acid (2-aminobenzoic acid)
Figure 10.1.2 Chemical structures of the matrices most commonly used for analyzing oligonu-
cleotides with MALDI-TOF MS.
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 2′,4′,6′-Trihydroxyacetophenone (THAP; Aldrich or Fluka)
 6-Aza-2-thiothymine (ATT; Aldrich)
Co-matrix: dibasic ammonium citrate or imidazole (Aldrich or Fluka)
Organic solvent, HPLC grade: 100% methanol (for THAP) or 50% aqueous
acetonitrile (for all other matrices)
Ultrapure (e.g., Nanopure) water
Ammonium-activated cation-exchange resin beads (see Support Protocol 1)
CAUTION: RNA samples are easily degraded by adventitious nucleases. If RNA is to be
purified or analyzed, all laboratory equipment must be sterilized prior to use. Use of gloves
is recommended during preparation of nucleic acid samples and solutions to avoid
contamination of glassware and other equipment. Autoclaved distilled water and the
highest available grade of salts must be used during solution preparation.
1. Weigh one of the following amounts of matrix and place in a 1.5-mL tube:
0.03 g 3-HPA;
0.03 g 3-HPA and 0.0075 g PA;
0.05 g THAP; or
0.04 g ATT.
2. Add 500 µL of appropriate organic solvent to matrix (Table 10.1.3). Vortex for 30
sec. Except for THAP (which can be used directly), allow solutions to settle and
remove supernatant for use with sample.
Matrix solution should be used quickly after preparation. Storage for >3 days is not
recommended.
3. Add ~50 mg of ammonium-activated cation-exchange resin beads to matrix solution.
Stir gently and allow to stand 30 min. Remove supernatant for use with sample.
Resin beads are included in matrix to reduce the formation of salt adducts. Using resin
beads is strongly recommended when highest-purity matrix (purity >98%) is not available.
4. Optionally, prepare co-matrix solution by adding either 0.23 g dibasic ammonium
citrate or 0.20 g imidazole to 10 mL water and vortexing until dissolved.
Ammonium citrate solution should be made fresh prior to use; storage for >3 days is not
recommended. Imidazole solution can be stored with Bio-Rad AG501-XG(d) resin beads
for up to 3 months.
Co-matrices are included in samples to reduce salt-adduct formation. Ammonium citrate
is recommended for samples that are not expected to contain nonvolatile (e.g., sodium or
potassium) salts, while imidazole is recommended for samples known to contain nonvola-
tile salts. Use of co-matrices is recommended even if the sample has been previously
Table 10.1.3 Guidelines for Preparation of UV Matrix Solutions
Matrix Solution
3-Hydroxypiconilic acid (3-HPA) Saturated (60 g/L) 3-HPA in 50:50 (v/v)
acetonitrile/water or in 25:75 (v/v)
methanol/water
3-Hydroxypiconilic acid/piconilic acid (PA) Saturated 3-HPA and 15 g/L PA in 50:50 (v/v)
acetonitrile/water
2′,4′,6′-Trihydroxyacetophenone (THAP) 100 g/L THAP in 50:50 (v/v) methanol (or
ethanol)/water or in 100% methanol
6-Aza-2-thiothymine (ATT) 80 g/L ATT in 50:50 (v/v) acetonitrile/water
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purified, as it tends to improve the quality of the mass spectral results, possibly through a
cooling mechanism during the desorption process (Simmons and Limbach, 1998).
BASIC
PROTOCOL 4Matrix/Analyte Sample Preparation
Typically oligonucleotides up to 20-mers in size can be analyzed at concentrations down
to the low femtomoles per microliter. To analyze larger oligonucleotides, more concen-
trated solutions—as much as 5 nmol/µl—are required. It is not critical that the sample,
matrix, and co-matrix (if used) be mixed prior to spotting on the sample plate, although
this is often done. A “two-layer” sample deposition method, similar to the sample
preparation method for peptides suggested by Vorm et al. (1994), is widely used for
oligonucleotides. In this protocol, the matrix solution is first deposited on the sample plate
and allowed to dry. The oligonucleotide solution, with or without additional matrix
solution, is then added on top of the dried matrix. The sample may be air-dried or drying
may be assisted by blowing a slow stream of gas (house air or nitrogen) at room
temperature over the sample.
Backbone-modified oligonucleotides in which the phosphodiester backbone is neutral-
ized (e.g., methylphosphonates) or nonexistent (e.g., peptide nucleic acids) should be
prepared and analyzed with MALDI-MS matrices used for peptides or protein analysis
(Keough et al., 1993, 1996; Butler et al., 1996; Ross et al., 1997). If the backbone-modified
oligonucleotide is not neutralized (e.g., phosphorothioates; Schuette et al., 1995; Polo et
al., 1997), the oligonucleotides should be prepared as described for unmodified oligonu-
cleotides.
This protocol details the procedure for preparing MALDI-MS sample solutions. If
2′,4′6′-trihydroxyacetopherone (THAP) is used as the matrix, follow steps 2b and 4b in
place of steps 2a and 4a.
Materials
Ultrapure (e.g., Nanopure) water
Matrix solution (see Basic Protocol 3)
Co-matrix solution (optional; see Basic Protocol 3)
Oligonucleotide sample, dry, lyophilized or as a 100- to 400-µM solution in
ultrapure water
CAUTION: RNA samples are easily degraded by adventitious nucleases. If RNA is to be
purified or analyzed, all laboratory equipment must be sterilized prior to use. Use of gloves
is recommended during preparation of nucleic acid samples and solutions to avoid
contamination of glassware and other equipment. Autoclaved distilled water and the
highest available grade of salts must be used during solution preparation.
1. If sample is in solid form, dissolve oligonucleotide sample in ultrapure water to a
concentration of 100 to 400 µM.
Lower concentrations are appropriate for small (<25-mer) oligonucleotides and higher
concentrations are necessary for large (>50-mer) oligonucleotides.
2a. To a 0.5-mL tube, add 4 µL matrix solution, 1 µL oligonucleotide solution, and
(optionally) 0.5 µL co-matrix solution.
2b. Alternative procedure for THAP: To a 0.5 mL tube, add 4 µL matrix solution and 1
µL co-matrix solution.
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 3. Mix by withdrawing and expelling the solution with the pipet 10 times.
4a. Spot 2 µL of solution on the sample plate and dry. To allow homogeneous crystal-
lization, do not disturb the spotted samples after they start to crystallize.
4b. Alternative procedure for THAP: Spot 2 µL of matrix/co-matrix solution on the
sample plate. Immediately spot 1 µL of the sample solution on top of the matrix
solution on the sample plate before the matrix begins to crystallize. To allow
homogeneous crystallization, do not disturb the spotted samples after they start to
crystallize.
IMPORTANT NOTE: Do not load the sample plate into the mass spectrometer before the
plate is dry. Good signal can be obtain anywhere around the edges of the crystallized spot.
INSTRUMENTATION
The Role of the Matrix
It is now agreed that the matrix plays several roles in promoting the formation of intact
molecular ions from the sample being analyzed: analyte isolation, absorption of laser
radiation, analyte desorption, and analyte ionization. The ability of the matrix to serve as
a solvent for the analyte is critical to the success of MALDI-MS. The matrix has molar
absorptivities much higher than the analyte, so the laser energy is preferentially deposited
in (absorbed by) the matrix. This process reduces subsequent fragmentation of the analyte,
improving the production of intact molecular ions. While the exact matrix characteristics
that facilitate analyte desorption are still the subject of investigation, it is presumed that
the laser energy absorbed by the matrix allows desorption of the first few layers of the
sample. Current research suggests heats of sublimation are an important consideration in
analyte desorption (Vertes et al., 1993; Bencsura et al., 1997). One of the more contentious
issues in MALDI-MS is the role of the matrix in the ionization process. The scenario most
commonly reported involves photoionization of the matrix molecule, which can then
react, by one of a number of possible pathways, to yield the analyte ion (Ehring et al.,
1992). A number of investigations aimed at better understanding the exact mechanism of
analyte ion formation have been performed, and presently there is no consensus whether
any one particular ion-formation pathway dominates the process (Dreisewerd et al., 1995;
Gimon-Kinsel et al., 1997). Most likely, analyte ion formation is influenced largely by
the chemical properties of the analyte and matrix used, and more than one pathway may
lead to the ultimate formation of the analyte ions detected in the mass spectrum.
Laser Source
Pulsed-nitrogen lasers (λ = 337 nm) are most commonly used in MALDI-MS and are the
standard lasers available on commercial instruments. IR lasers were used in some early
studies of MALDI-MS, and have recently received additional attention because they give
results strikingly similar to those of UV-MALDI lasers (Niu et al., 1998). In some cases,
IR lasers are more successful than UV lasers at characterizing higher-molecular-weight
samples (Berkenkamp et al., 1997, 1998).
Operationally, laser fluences on the order of 106 to 107 W/cm2 with spot sizes around 10
to 100 µm are common in MALDI-MS. The best results are achieved by working at or
just above the threshold irradiance necessary to generate analyte signal. (Threshold
laser-power density is the minimum laser-power density necessary to obtain reproducible
signal.) To achieve the appropriate laser irradiance, various means of attenuating the laser
output are typically employed; these are common accessories on commercial instruments.
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Time-of-Flight Mass Analyzer
The most common instrument configuration is a MALDI ion source coupled to a
time-of-flight (TOF) mass analyzer (Fig. 10.1.3). Separation of ions of different m/z
values in TOF mass spectrometry is accomplished by accelerating the ions through a short
20- to 30-kV electric field, allowing them to drift through a field-free region, and
measuring the total flight time from ion formation to impact on an electron-multiplier
detector. Lower-mass ions have shorter flight times than higher-mass ions and thus, by
calibrating the ions’ flight times through the instrument using standards of known mass,
a mass spectrum can be obtained.
An ion’s flight time is proportional to the square root of the mass-to-charge ratio of
the ion and is proportional to the length of its flight path, as shown in the following
equation:
t = √m2zeVacc  L
where t is the ion’s flight time in seconds, m is its mass in kilograms, z is the number of
charges on the ion, e is the fundamental charge (1.6 × 10−19 C), Vacc is the accelerating
voltage in the ion source in volts, and L is the total flight path in meters.
The mass spectral resolution (R) between two ions, m and m + ∆m, is proportional to the
flight time of the ion divided by twice the time interval of ion arrival at the detector:
R = m
∆m
 = 
t
2∆t
As is evident from this equation, longer flight paths typically result in higher mass-spectral
resolution than do shorter flight paths.
To avoid detector saturation by the matrix ions present in large excess in the sample, most
commercial instruments are equipped with a low-mass ion gate. Low-mass matrix ions
are deflected by an electrode that has a low potential of the same polarity as the ions and
that is located in front of the detector, or the detector is turned on immediately after these
low-mass ions reach it.
The most important instrumental factor limiting MALDI mass analysis of oligonu-
cleotides is the instability of gas-phase oligonucleotide ions, which results in a continuous
Figure 10.1.3 Schematic diagram of a linear MALDI-TOF mass spectrometer.
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fragmentation process beginning immediately as the ions are formed and continuing until
they are detected (Fig. 10.1.4). There are essentially four differing time scales for
desorption/ionization-induced dissociations in MALDI time-of-flight mass spectrometry
(MALDI-TOF MS): prompt, fast, fast metastable, and metastable.
1. Prompt dissociations occur on a time scale equal to or less than that of the desorption
event.
Figure 10.1.4 (a) Nordhoff (Nordhoff et al., 1995) and (b) McLuckey (McLuckey et al., 1992)
nomenclature for the dissociation products of oligonucleotides. The McLuckey nomenclature is
generally followed in the literature because of its applicability to ESI-MS as well as MALDI-MS.
(c) Prevalent oligonucleotide fragmentation mechanism in UV-MALDI-MS (Nordhoff et al., 1995).
Base protonation initiates base loss at purine sites as a result of cleavage at the N-glycosidic bond,
which leads to subsequent cleavage of the phosphodiester backbone at the 3′-CO bond. Fragment
ions here are denoted using the Nordhoff nomenclature.
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2. Fast dissociations occur after the desorption event, but before or at the beginning of
the acceleration event.
3. Fast metastable decays occur on the time scale of the acceleration event.
4. Metastable decays occur after the acceleration event, during the field-free flight time
of the ion.
In addition, the initial kinetic energy distribution and the presence of salt adducts can
reduce the quality of mass-spectral results. To date, instrumentation improvements are
able to reduce the deleterious effects of kinetic energy spread and ion formation. As
mentioned above, reduction of the fragmentation processes can be achieved through proper
matrix selection or through modification of the oligonucleotide structure. Adduct peaks can
only be eliminated by appropriate purification techniques prior to mass analysis.
The sensitivity, resolution, and mass accuracy depend on the particular TOF configuration
used. MALDI was first coupled with basic linear TOF (L-TOF) instruments (Fig. 10.1.3),
in which ions are continuously accelerated for less than a few hundred nanoseconds. Less
fragmentation is observed than in other instrument configurations: fragmentation that
occurs after ions leave the acceleration region and enter the field-free region will not be
detected, because the L-TOF instrument cannot differentiate the parent and fragment ions. A
significant disadvantage of continuous-extraction L-TOF is that it cannot reduce peak
broadening occurring from the initial velocity distribution of ions. Typically (e.g., see Wu et
al., 1994) this results in poor resolution and mass accuracy, with oligonucleotides larger than
50-mers yielding resolutions on the order of 20 to 60 FWHM (full-width half-maximum).
Time-lag focusing, commonly referred to as delayed extraction (DE), was coupled to TOF
as a means of reducing the initial velocity spread of ions while they are still in the
accelerating region of the mass spectrometer (Colby et al., 1994; Brown and Lennon,
1995; Vestal et al., 1995). In the DE mode of operation, a second electrostatic gate is
included in the ion-source region. During the laser pulse, this electrode is held at a
potential sufficient to prevent the acceleration of the laser-desorbed ions into the field-free
region. After a suitable delay period, which is mass dependent (Vestal et al., 1995), the
ions are accelerated into the field-free region and analyzed as usual. DE L-TOF instru-
ments achieve very reasonable resolution (∼1000 FWHM) and lower mass errors (∼0.01%
to 0.1%) for oligonucleotides up to 50-mers (Juhasz et al., 1996).
A common instrumental approach for increasing the flight path, which has the added
advantage of addressing a higher-order ion-focusing problem, is the addition of an
electrostatic mirror at the end of the flight tube that reverses the ion’s direction and
refocuses it toward the detector. This “reflectron” TOF (re-TOF) mass analyzer increases
the path-length of the ion, yielding longer flight times and hence higher mass-spectral
resolution. The electrostatic ion mirror compensates for the initial kinetic energy
spread of the ions, thereby improving the focusing of ions of a single m/z more
effectively at the detector (Fig. 10.1.5). In addition, delayed-extraction can be com-
bined with a reflectron time-of-flight mass analyzer to yield a “high-performance”
MALDI mass spectrometer with resolution approaching 15,000 FWHM and part-per-
million mass errors. The use of a reflectron can resolve metastable dissociations, but
unless certain parameters are adjusted (Spengler, 1997), these ions appear as uninfor-
mative broad peaks.
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INSTRUMENT CALIBRATION
The mass axis in TOF-MS is normally calibrated via a two-point calibration procedure.
Calibration can be performed externally or internally; the latter provides higher mass
accuracies. As is typical in TOF-MS, the two calibrant masses should bracket the mass(es)
of interest. For small oligonucleotides (<10-mers), matrix peaks can serve as the lower-
mass calibration point. Doubly charged molecular ions often appear at abundances
significant enough to serve as a check for the mass calibration. For larger oligonucleotides,
the two calibration masses must be from ions other than those from the matrix. Peptides
and proteins are not suitable as calibrants for oligonucleotides. The concentration of the
calibrants should be the same as the concentration of the analytes, especially when internal
calibration is used. Because the initial ion velocities depend on the laser power density
(Spengler and Bokelmann, 1993) and the matrix (Juhasz et al., 1997; see also references
therein), internal calibration is necessary in L-TOF-MS, because this configuration
cannot correct for the initial velocity distribution of the ions. On the other hand,
DE-TOF and re-TOF instruments can mitigate those factors and external calibration
Figure 10.1.5 Schematic diagram of a reflectron MALDI-TOF mass spectrometer. Higher-energy
ions penetrate the ion mirror further than lower-energy ions, allowing them to be focused to a
common point at the detector.
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yields satisfactory results; internal calibration can still be used, however, and will provide
better accuracy.
Caution should be exercised when assigning accurate molecular weights of the calibrants.
In L-TOF, the average molecular weight should be used, because this configuration will
not resolve the 13C isotope peaks. The centroid of a peak (the mass value at the center of
the peak) is preferred to the peak top when assigning molecular weights to ions whose
isotopes have not been resolved. The centroid at 50% of the peak height may be used to
avoid including trace cation-adduct peaks in the molecular weight assignment. Peak tops
may be used to assign molecular weights of calibrants for instrument configurations that
resolve the 13C isotope peaks. Calibrants producing abundant cation adducts should be
avoided to minimize errors in molecular-weight assignments.
MOLECULAR WEIGHT DETERMINATION USING MALDI-MS
MALDI-MS analysis of oligonucleotides is typically performed in the negative-ion mode,
due to its higher sensitivity, higher resolution, and lower fragmentation compared to
positive-ion-mode analysis (Stemmler et al., 1995; Tang et al., 1997a). The best mass-
spectral data is obtained at near-threshold laser-power densities. Threshold laser-
power density varies by matrix (Wu et al., 1993; Gusev et al., 1995) and is usually
higher for oligonucleotide analysis than for peptide analysis (Wu et al., 1993). Laser
power higher than threshold may produce higher oligonucleotide-ion abundance.
However, as mentioned previously, the fragmentation and peak resolution are depend-
ent on the laser-power density, and operating at laser powers significantly above
threshold may degrade the quality of the mass spectrum. One should always be aware
that signal abundance will vary from spot to spot within the same sample, due to the
heterogeneous matrix/analyte crystals. The large shot-to-shot variability typically
precludes the use of MALDI-MS in quantitative analysis, except under special
experimental conditions (Bruenner et al., 1996).
OLIGONUCLEOTIDE AND NUCLEIC ACID SEQUENCING USING
MALDI-MS
MALDI-MS is becoming the method of choice for rapid and accurate analysis of smaller
synthetic oligonucleotides after the products are purified (Keough et al., 1993; Wang and
Biemann, 1994), and is suitable as a quality control method in oligonucleotide synthesis
(Ball and Packman, 1997). Sequence information from synthetic oligonucleotides can be
obtained using several different approaches, of which the two most successful are
failure-sequence analysis and exonuclease digestion—both dependent on the formation
of a “mass ladder” (Limbach, 1996; Nordhoff et al., 1996) and hence well-suited to
MALDI-MS. Sequence information arising from the formation of a mass ladder is
obtained by determining the mass difference between successive peaks in the mass
spectrum (Table 10.1.4 and Fig. 10.1.6). As is the case for all sequence-determination
Table 10.1.4 Characteristic Mass Losses for Naturally Occurring Deoxynucleotides (dX) and
Ribonucleotides (rX)a
Nucleotide Mass loss Nucleotide Mass loss
dA 313.27 rA 329.27
dG 329.27 rG 345.27
dC 289.25 rC 305.25
dT 304.26 rU 306.26
aSeen during failure sequence analysis or exonuclease digestion. All mass values are atomic weight based.
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methods that rely on the mass measurements of successive n-mers, oligodeoxynucleotides
are easier to characterize than oligoribonucleotides due to the relatively large differences
in mass among the four oligodeoxynucleotide residues. Because of the small mass
difference between U- and C-containing nucleotides (only 1 u), ribonucleotide analysis
requires a higher mass accuracy to correctly distinguish Us from Cs. Furthermore, all
mass-ladder methods have a distinct advantage for sequence determination because it is
the difference in two mass measurements that results in the desired information—the
identity of the nucleotide residue.
Detection of failure sequences from the original synthesis step is one of the simplest
methods for characterizing the chain length and sequence of synthetic oligonu-
cleotides (Keough et al., 1993; Butler et al., 1996; Juhasz et al., 1996). This simple
and straightforward method takes advantage of the fact that automated solid-phase
synthesis of oligonucleotides, especially those containing modified internucleotide link-
ages such as methylphosphonates or phosphorothioates, is not 100% efficient. The mass
spectrum will therefore contain a series of peaks that correspond to the final product and
to each failure sequence, each of which differs in mass by the appropriate nucleotide
residue value. The sequence of the oligonucleotide is determined in the 5′-to-3′ direction
from the mass ladder of the synthesis failure products.
The use of exonucleases to generate mass ladders of oligonucleotides that are suitable for
analysis by mass spectrometry is now a standard method for sequencing small to
moderate-length oligonucleotides—up to 30-mers for L-TOF without DE and 50-mers
for DE-TOF (Pieles et al., 1993; Limbach, 1996). Unlike the failure-sequence analysis
method described above, this approach is suitable for the sequence analysis of
naturally occurring oligonucleotides. Two exonucleases are commonly used. Phos-
phodiesterase I, or snake venom phosphodiesterase (SVP), is a 3′-to-5′ exonuclease
that is inhibited by a 3′-terminal phosphate and will generate 3′-to-5′ sequence
information, while phosphodiesterase II, or calf spleen phosphodiesterase (CSP), is a
5′-to-3′ exonuclease that is inhibited by a 5′-terminal phosphate and will generate 5′
to 3′ sequence information.
SVP digestion of an oligonucleotide is generally more rapid than CSP digestion and
is not inhibited by the presence of base- or sugar-modified nucleosides. CSP is
Figure 10.1.6 MALDI mass spectrum of 3′-to-5′ exonuclease digestion of d(GCCCAAGCTG).
After 25 min of digestion, nearly all of the oligonucleotide sequence can be determined.
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inhibited by 2′-O-methyl-modified nucleosides (Pieles et al., 1993). Such inhibition
may be advantageous when base- and sugar-methyl-modifications must be distin-
guished in the overall sequence. Digestion with SVP would locate methyl-modified
nucleosides, and digestion with CSP would distinguish between a base or sugar
modification. Typically, complete sequence coverage of moderate-length (15 to 50 nt)
oligonucleotides can be achieved within a 20- to 40-min reaction period, depending
on the enzyme and digestion conditions used (Bentzley et al., 1996; Tolson and
Nicholson, 1998).
BASIC
PROTOCOL 5Oligonucleotide or Nucleic Acid Sequencing Using Sequential Exonuclease
Digestion and MALDI-TOF MS
This protocol describes the procedure for exonuclease sequencing of oligonucleotides or
nucleic acids using MALDI-TOF MS. SVP, which cleaves oligonucleotides in the 3′-to-5′
direction, should be used to generate 3′ sequence information while CSP, which cleaves
in the opposite direction, should be used if 5′ sequence information is required. During
the first few minutes of analysis, information can be gathered on the first five or so
nucleotides in the sequence. After longer reaction times, sequence information can be
obtained for nucleotides further along the chain (Limbach, 1996; Smirnov et al., 1996).
The ultimate time for analysis is dependent on the size of the oligonucleotide and the rate
of digestion, and is determined empirically.
The buffer solutions used here are compatible with the matrices, and therefore matrix
desalting is typically not required. Sample purification should be performed as needed
just prior to sequencing.
Materials
5-µg oligonucleotide sample, lyophilized
Ultrapure (e.g., Nanopure) water
50 g/L dibasic ammonium citrate, pH ∼6.4 (unadjusted)
10% (v/v) aqueous ammonium hydroxide
1 × 10−4 U/µL phosphodiesterase I (from snake venom; SVP; Sigma) or 1 × 10−3
unit/µL phosphodiesterase II (from calf spleen; CSP; Sigma or Worthington
Biochemical) in ultrapure water
Matrix (see Basic Protocol 3)
Dry ice
CAUTION: RNA samples are easily degraded by adventitious nucleases. If RNA is to be
purified or analyzed, all laboratory equipment must be sterilized prior to use. Use of gloves
is recommended during preparation of nucleic acid samples and solutions to avoid
contamination of glassware and other equipment. Autoclaved distilled water and the
highest available grade of salts must be used during solution preparation.
1. Dissolve oligonucleotide sample in ultrapure water to a concentration of 100 to 400
µM (200 µM is optimum).
2. If performing 3′-to-5′ sequencing using SVP: Adjust ammonium citrate solution to
pH 9.4 with 10% aqueous ammonium hydroxide.
3. Mix 4 to 5 µL phosphodiesterase and 1 µL ammonium citrate solution with 5 µL of
oligonucleotide solution in a microcentrifuge tube. Close the tube and vortex the
reaction mixture.
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4. Place reaction mixture in 37°C water bath and allow temperature to equilibrate.
5. Every 10 min, remove a 1- to 2-µL aliquot of the reaction mixture.
6a. Quickly mix the aliquot with appropriate volume of matrix solution and place in dry
ice to quench reaction. Either immediately spot samples on the sample plate or retain
them to be tested all together after all digestion aliquots are obtained.
6b. Alternatively, analyze the reaction mixture aliquot immediately by MALDI-TOF MS.
Aliquots must be either quenched or analyzed immediately to limit further enzymatic
digestion.
Future Developments: Full-Scale Oligonucleotide Sequencing
As mentioned earlier, there are essentially four differing time scales for desorption/ioni-
zation-induced dissociations in MALDI-TOF MS: prompt, fast, fast metastable, and
metastable. In theory, dissociations occurring during any one of these time scales will
generate fragment ions that could be used to determine the sequence of the oligonu-
cleotide. In practice, unless certain instrumental parameters are manipulated, most of
these fragments result in a broadening of the molecular ion peak with a concomitant loss
of resolution and sensitivity.
Because of these drawbacks and because this sequencing method provides little control
over the extent of fragmentation, there are few reports of the use of desorption/ionization-
induced fragmentation to determine oligonucleotide sequences. As mentioned earlier,
instrument configurations will to a large extent determine the type of fragment ions that
can be detected in the mass spectrum. Currently, the use of desorption/ionization-induced
fragment ions for sequence determination of oligonucleotides is limited. The mechanisms
of prompt fragment-ion production have been studied in some detail (Fig. 10.1.4;
Nordhoff et al., 1995; Zhu et al., 1995), and fragmentation patterns appear to be similar
to those found in ESI–tandem mass spectrometry (ESI-MS/MS) studies of oligonu-
cleotides (see UNIT 10.2), suggesting that routine use of this method for sequence determi-
nation may be possible in the near future.
As mentioned previously, analogs of nucleotides are more stable than natural oligonu-
cleotides in MALDI-TOF MS. 7-Deazapurines have a carbon instead of a nitrogen at
position 7 in the nucleobase—thought to be the site at which the protonation leading to
oligonucleotide fragmentation occurs in the gas phase (Nordhoff et al., 1993; Schneider
and Chait, 1993). The modification on 2′-fluoro-nucleotides makes the N-glycosidic bond
stronger, preventing nucleobase loss (Zhu et al., 1995). Although DE-TOF MS has been
used for the complete sequence assignment of the desorption/ionization-induced frag-
ments of an 11-mer oligodeoxynucleotide (Juhasz et al., 1996), the fragmentation mecha-
nisms are not understood and no other oligonucleotides have been characterized using
this approach.
There has been considerable interest in the use of MALDI-TOF MS to replace current
gel-based separation and radioactive or fluorescent detection schemes for enzymatically
synthesized oligonucleotides. By overlapping four sets of Sanger sequencing products
that are terminated at guanosine, adenosine, cytidine, and thymidine, respectively, the
sequence of the oligonucleotide of interest can be determined. In the first report of this
approach (Fitzgerald et al., 1993b), a mock sequencing experiment was performed in
which machine-synthesized oligodeoxynucleotides, corresponding to the expected nested
set of oligodeoxynucleotides in a Sanger approach, were analyzed using MALDI-TOF
MS. The sequence of a potential DNA fragment could be determined up to 18 bases past
the primer (a 35-mer overall) before the signal ceased to be observed.
Current Protocols in Nucleic Acid Chemistry
10.1.20
Analysis  of
Oligonucleotides 
Because of the buffers and other components in these reaction mixtures, however, the use
of MALDI-MS to analyze actual Sanger dideoxy-termination sequencing reactions has
proven to be much more difficult. Shaler et al. (1995) characterized the products from a
dideoxy reaction catalyzed by a modified T7 DNA polymerase system. Working with
picomole quantities of material, they were able to read the sequence out to the 19th base
past the 12-mer primer. Using a 21-mer as the primer, the complete sequence could be
determined for a 45-base synthetic template. Roskey and coworkers have analyzed the
primer extension products from the Sanger reaction of a 50-base template with a 13-base
primer; the use of a higher-resolution DE-MALDI-TOF mass spectrometer for the
analyses afforded sequence information out to the 32nd base past the primer (Roskey et
al., 1996). Mouradian and coworkers have performed mass spectrometric analysis of the
primer-extension products that are generated from the M13 bacteriophage DNA template
that is commonly used in actual Sanger sequencing (Mouradian et al., 1996; Roskey et
al., 1996) and obtained sequence information out to the 18th base past the primer. Clearly
more work is needed in this area before mass spectrometry in combination with the Sanger
method becomes a viable alternative to traditional gel- or capillary-based separation and
detection schemes.
ANALYSIS OF POLYMERASE CHAIN REACTION PRODUCTS USING
MALDI-MS
A promising application of MALDI-MS is in the identification of DNA fragments
amplified using the polymerase chain reaction (PCR). PCR allows selected regions of
DNA extracted from a variety of sample sources to be amplified to a detectable level.
PCR primers may be designed to produce amplified DNA products of anywhere from ten
to hundreds of nucleotide residues. One impediment to high-accuracy analysis of PCR-
amplified fragments is the presence of buffers, primers, and nucleoside triphosphates,
which can interfere with the mass-spectral analysis.
A number of investigators have analyzed PCR-amplified fragments by MALDI-MS
(Limbach, 1996). The combination of PCR and mass spectrometry shows the potential
to be used as a rapid and accurate method for DNA diagnostics. Applications have
included the analysis of human and bacterial DNA fragments. MALDI mass spectromet-
ric analysis of PCR-amplified fragments has been used to distinguish a three-base deletion
site in the cystic fibrosis transmembrane conductance regulator, which is characteristic
of patients with cystic fibrosis (Ch’ang et al., 1995), and to distinguish genetic polymor-
phisms in human DNA (Liu et al., 1995b). Legionella pneumophila, the causative agents
of Legionnaire’s disease, has been identified using MALDI-MS (Hurst et al., 1996).
SUMMARY
The speed and sensitivity of mass spectrometric analyses make this an attractive approach
to analyzing oligonucleotides and nucleic acids. With the advent of “soft” ionization
techniques such as MALDI-MS and ESI-MS, the ability to analyze these molecules in
their intact form has brought mass spectrometry into the forefront as a viable means for
characterizing them. MALDI-MS is well-adapted for rapid characterization of oligonu-
cleotides because of its relatively high tolerance of sample impurities, ease of spectral
interpretation (resulting from the fact that predominantly singly charged ions are formed),
and ability to handle complex mixtures of oligonucleotides. The rapid pace of technologi-
cal development and the expected developments in understanding and reducing the causes
of oligonucleotide fragmentation, should result in significant experimental advances in
this area of analysis in the near future.
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